Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Kelsen

Showing results (81-90 of 129) with videos related to

Pageof 13
Sort By:
Cancer|November 26, 1999
Paclitaxel in the treatment of patients with angiosarcoma of the scalp or faceF Fata, E O'Reilly, D Ilson, et al.
Cancer Investigation|January 1, 1985
Phase I study of elliptinium (2-N-methyl-9-hydroxyellipticinium)A I Einzig, R J Gralla, B R Leyland-Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Phase I trial of PN401, an oral prodrug of uridine, to prevent toxicity from fluorouracil in patients with advanced cancerD P Kelsen, D Martin, J O'Neil, et al.
American Journal of Clinical Oncology|April 1, 1982
Phase II trials of methylglyoxal-bis (guanylhydrazone)D P Kelsen, A Yagoda, R Warrell, et al.
Cancer Treatment Reports|November 1, 1985
Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasoneM G Kris, R J Gralla, R A Clark, et al.
Journal of Surgical Oncology|March 20, 1999
30 Gy may be an adequate dose in patients with anal cancer treated with excisional biopsy followed by combined-modality therapyK Hu, B D Minsky, A M Cohen, et al.
Cancer|October 15, 1994
A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancerD P Kelsen, L Saltz, A M Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1990
Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapyD P Kelsen, B Minsky, M Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1985
Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatinM G Kris, R J Gralla, R A Clark, et al.
Cancer Research|October 1, 1990
11p13-15 is a specific region of chromosomal rearrangement in gastric and esophageal adenocarcinomasE Rodriguez, P H Rao, M Ladanyi, et al.
Pageof 13

Showing results (81-90 of 129) with videos related to

Sort By:
Pageof 13
Cancer|November 26, 1999
Paclitaxel in the treatment of patients with angiosarcoma of the scalp or faceF Fata, E O'Reilly, D Ilson, et al.
Cancer Investigation|January 1, 1985
Phase I study of elliptinium (2-N-methyl-9-hydroxyellipticinium)A I Einzig, R J Gralla, B R Leyland-Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Phase I trial of PN401, an oral prodrug of uridine, to prevent toxicity from fluorouracil in patients with advanced cancerD P Kelsen, D Martin, J O'Neil, et al.
American Journal of Clinical Oncology|April 1, 1982
Phase II trials of methylglyoxal-bis (guanylhydrazone)D P Kelsen, A Yagoda, R Warrell, et al.
Cancer Treatment Reports|November 1, 1985
Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasoneM G Kris, R J Gralla, R A Clark, et al.
Journal of Surgical Oncology|March 20, 1999
30 Gy may be an adequate dose in patients with anal cancer treated with excisional biopsy followed by combined-modality therapyK Hu, B D Minsky, A M Cohen, et al.
Cancer|October 15, 1994
A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancerD P Kelsen, L Saltz, A M Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1990
Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapyD P Kelsen, B Minsky, M Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1985
Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatinM G Kris, R J Gralla, R A Clark, et al.
Cancer Research|October 1, 1990
11p13-15 is a specific region of chromosomal rearrangement in gastric and esophageal adenocarcinomasE Rodriguez, P H Rao, M Ladanyi, et al.
Pageof 13